Sarcoidosis, Pulmonary clinical trials
The registry lists 67 studies for Sarcoidosis, Pulmonary across more than 10 countries. 16 are recruiting or about to start. 57 of them are mainly about Sarcoidosis, Pulmonary (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Sarcoidosis, Pulmonary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Xentria, Inc. (3) · University of Cincinnati (3) · Post Graduate Institute of Medical Education and Research, Chandigarh (3) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Alexandria University (2) · Istanbul University - Cerrahpasa (2) · aTyr Pharma, Inc. (2) · Turku University Hospital (2)
What is being tested here
Drugs under test in Sarcoidosis, Pulmonary studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Corticosteroids 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4, phase 3 first
- Jul 2027Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis · Phase 3 · Peking Union Medical College Hospital
- Nov 2026Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis · China-Japan Friendship Hospital
- Jul 2027A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension · Cosmos Rx, Inc
- Aug 2027Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis · Molecure S.A.
Who these studies take
Of the 12 Sarcoidosis, Pulmonary studies recruiting now, 7 (58%) set no upper age limit and 1 (8%) stop at 75 or younger. 2 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (17%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (17%) | 2 (17%) |
| 18 | 11 (92%) | 11 (92%) |
| 30 | 12 (100%) | 12 (100%) |
| 40 | 12 (100%) | 12 (100%) |
| 50 | 12 (100%) | 12 (100%) |
| 65 | 12 (100%) | 12 (100%) |
| 75 | 12 (100%) | 12 (100%) |
| 85 | 10 (83%) | 10 (83%) |
Across all 67 studies, recruiting or not: 21% stop at 75 or younger and 6% at 65; 6% take children; 1% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 14, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 → or search them.
- Role of Genetic Factors in the Development of Lung DiseaseRecruitingNCT000015321 country
- A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016)RecruitingNCT07867938Phase 21 country
- An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary ManifestationsNot yet recruitingNCT07680166Phase 2
- Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary SarcoidosisNot yet recruitingNCT07668895Phase 2/31 country
- Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary SarcoidosisRecruitingNCT06205121Phase 28 countries
- Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary SarcoidosisRecruitingNCT05841758Phase 41 country
- A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary HypertensionNot yet recruitingNCT076132161 country
- Feasibility of Semaglutide in Advanced Lung DiseaseRecruitingNCT05746039Phase 1/21 country
- Risk Indicators of Sarcoidosis Evolution-Unified ProtocolRecruitingNCT055671331 country
- Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected SarcoidosisRecruitingNCT06853834Not applicable1 country
- Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary SarcoidosisEnrolling by invitationNCT03755245Not applicable1 country
- RCT of Nintedanib in Fibrotic SarcoidosisRecruitingNCT06479603Phase 41 country
- Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung DiseaseRecruitingNCT03455686Not applicable1 country
- Study Comparing Chronic Beryllium Disease to Pulmonary SarcoidosisRecruitingNCT061139911 country
- Epigenetic Regulation of Altered T-cell Immunity in SarcoidosisRecruitingNCT031459221 country
- Feasibility & Effect of a Tele-rehabilitation Program in Pulmonary Sarcoidosis Pulmonary SarcoidosisRecruitingNCT03914027Not applicable1 country
- An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary SarcoidosisCompletedNCT06169397Phase 24 countries
- Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary SarcoidosisTerminatedNCT02824419Phase 2/31 country
- Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary ManifestationsActive, not recruitingNCT05890729Phase 1/26 countries
- Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II SarcoidosisActive, not recruitingNCT07246876Not applicable1 country
- Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisCompletedNCT05415137Phase 39 countries
- Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal AdenopathyCompletedNCT05374447Not applicable1 country
- Pulmonary Rehabilitation in Patients With SarcoidosisCompletedNCT02044939Not applicable1 country
- the PHENOSAR Trial: Use of Antibiotics in Treatment of SarcoidosisActive, not recruitingNCT05291468Not applicable1 country
- Sarcoidosis Immunotsuppressive Therapy and Lymphoma DevelopmentCompletedNCT073434011 country
- A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary SarcoidosisTerminatedNCT05314517Phase 27 countries
- Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary SarcoidosisCompletedNCT04064242Phase 26 countries
- Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary SarcoidosisActive, not recruitingNCT04314193Phase 41 country
- Investigation of the Efficacy of Metformin Therapy on Pulmonary SarcoidosisWithdrawnNCT05910554Phase 2
- Comparison of Different Exercise Training on Exercise Capacity and Fatigue in Patients With SarcoidosisCompletedNCT05368883Not applicable1 country
- Peripheral Airway Biopsy in SarcoidosisCompletedNCT05759221Not applicable1 country
- Endobronchial Ultrasound Strain Elastography in SarcoidosisStatus unknownNCT048951111 country
- Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary SarcoidosisCompletedNCT03824392Phase 1/21 country
- CASPA: CArdiac Sarcoidosis in PApworthCompletedNCT035994141 country
- SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic SarcoidosisCompletedNCT03140644Not applicable1 country
- The Diagnostic and Prognostic Role of SAA in Intrathoracic SarcoidosisCompletedNCT058119621 country
- An RCT of NBI vs. White Light Guided Endobronchial Biopsy in Suspected SarcoidosisCompletedNCT05311150Not applicable1 country
- Acthar Gel in Participants With Pulmonary SarcoidosisCompletedNCT03320070Phase 41 country
- Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of SarcoidosisCompletedNCT03265405Phase 41 country
- A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or SarcoidosisCompletedNCT03727451Phase 21 country
- The Effect of Inspiratory Muscle Training and Breathing Exercises Combined With Upper Extremity and Trunk in Patients With SarcoidosisCompletedNCT04173689Not applicable1 country
- Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary SarcoidosisStatus unknownNCT05247554Phase 3
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent SarcoidosisCompletedNCT03793439Phase 11 country
- Study of Nicotine Patches in Patients With SarcoidosisCompletedNCT00701207Early Phase 11 country
- Breath Analysis in Patients With Suspected Sarcoidosis: The VOCs-IS StudyCompletedNCT043183921 country
- Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary SarcoidosisCompletedNCT02888080Phase 23 countries
- Endobronchial Mucosal Biopsy in Patients With Suspected Pulmonary SarcoidosisCompletedNCT04904939Not applicable1 country
- Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung DiseaseCompletedNCT048036171 country
- The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary SarcoidosisCompletedNCT01587001Not applicable1 country
- Azithromycin a Treatment for Pulmonary SarcoidosisCompletedNCT04020380Phase 21 country